These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34257396)

  • 21. Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample.
    Jones G; Lipson J; Wang E
    Sci Rep; 2023 Feb; 13(1):2466. PubMed ID: 36774449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents.
    Jones G; Arias D; Nock M
    Sci Rep; 2022 Dec; 12(1):21927. PubMed ID: 36535992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychedelic use and intimate partner violence: The role of emotion regulation.
    Thiessen MS; Walsh Z; Bird BM; Lafrance A
    J Psychopharmacol; 2018 Jul; 32(7):749-755. PubMed ID: 29807492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample.
    Jones G; Ricard JA; Hendricks P; Simonsson O
    J Psychopharmacol; 2022 Oct; 36(10):1129-1135. PubMed ID: 36189781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lifetime use of MDMA/ecstasy and psilocybin is associated with reduced odds of major depressive episodes.
    Jones GM; Nock MK
    J Psychopharmacol; 2022 Jan; 36(1):57-65. PubMed ID: 34983261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring protective associations between the use of classic psychedelics and cocaine use disorder: a population-based survey study.
    Jones GM; Nock MK
    Sci Rep; 2022 Feb; 12(1):2574. PubMed ID: 35173246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case analysis of long-term negative psychological responses to psychedelics.
    Bremler R; Katati N; Shergill P; Erritzoe D; Carhart-Harris RL
    Sci Rep; 2023 Sep; 13(1):15998. PubMed ID: 37749109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations between classic psychedelics and nicotine dependence in a nationally representative sample.
    Jones G; Lipson J; Nock MK
    Sci Rep; 2022 Jun; 12(1):10578. PubMed ID: 35732796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year.
    Simonsson O; Hendricks PS; Carhart-Harris R; Kettner H; Osika W
    Hypertension; 2021 May; 77(5):1510-1516. PubMed ID: 33677982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychedelics not linked to mental health problems or suicidal behavior: a population study.
    Johansen PØ; Krebs TS
    J Psychopharmacol; 2015 Mar; 29(3):270-9. PubMed ID: 25744618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database.
    Brixner D; Ghate SR; McAdam-Marx C; Ben-Joseph R; Said Q
    J Manag Care Pharm; 2008 Oct; 14(8):756-67. PubMed ID: 18983205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Classic psychedelic use and current meditation practice.
    Simonsson C; Chambers R; Hendricks PS; Goldberg SB; Osika W; Schlosser M; Ryde A; Christersson E; Simonsson O
    Mindfulness (N Y); 2023 Apr; 14(4):763-768. PubMed ID: 37693239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychedelic use and psychiatric risks.
    Simonsson O; Goldberg SB; Chambers R; Osika W; Simonsson C; Hendricks PS
    Psychopharmacology (Berl); 2023 Oct; ():. PubMed ID: 37874345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between psychedelic use, abuse, and dependence and lifetime panic attack history in a representative sample.
    Bonn-Miller MO; Bernstein A; Sachs-Ericsson N; Schmidt NB; Zvolensky MJ
    J Anxiety Disord; 2007; 21(5):730-41. PubMed ID: 17067775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.
    Zeifman RJ; Singhal N; Breslow L; Weissman CR
    ACS Pharmacol Transl Sci; 2021 Apr; 4(2):436-451. PubMed ID: 33860173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Personality traits explain the relationship between psychedelic use and less depression in a comparative study.
    Sjöström DK; Claesdotter-Knutsson E; Kajonius PJ
    Sci Rep; 2024 May; 14(1):10195. PubMed ID: 38702496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA and psilocybin) and psychological distress and suicidality.
    Jones GM; Nock MK
    Sci Rep; 2022 Oct; 12(1):16976. PubMed ID: 36216840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics.
    Wilkes R; Roberts DM; Liknaitzky P; Brett J
    Clin Toxicol (Phila); 2024 Apr; 62(4):242-247. PubMed ID: 38753585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes.
    Jones GM
    J Psychopharmacol; 2023 Jan; 37(1):61-69. PubMed ID: 36314881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychedelic Knowledge and Opinions in Psychiatrists at Two Professional Conferences: An Exploratory Survey.
    Barnett BS; Beaussant Y; King F; Doblin R
    J Psychoactive Drugs; 2022; 54(3):269-277. PubMed ID: 34409921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.